Randomized Phase II Study of Cetuximab in Combination With Gemcitabine or Gemcitabine Followed by Cetuximab in Advanced Non Small-Cell Lung Cancer Patients Who Are Not Candidates for Platinum Based Therapy.
Phase of Trial: Phase II
Latest Information Update: 17 May 2012
At a glance
- Drugs Cetuximab; Gemcitabine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms CALC1; CALC1-E; CALC1-PS2
- 02 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Sep 2008 Results reported at ESMO 2008.
- 29 Jul 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History